🔎 Trials Near Me

Почетна › Беркитов лимфом › Њујорк › New York City

Kliničke studije za Беркитов лимфом u gradu New York City, NY

13 studija za Беркитов лимфом traži učesnike na lokacijama u gradu New York City i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Asciminib and Inotuzumab Ozogamicin for Relapsed or Refractory Philadelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia (R/R Ph+ B-ALL)

Тражи се учесникФаза 1
  • Columbia University Irving Medical Center, New York
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07936266

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Тражи се учесникФаза 2
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
  • и још 1
Узраст од 1 до 30 · Оба пола · Ажурирано 12. 11. 2026. · NCT04546399

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

Тражи се учесникФаза 3
  • Memorial Sloan Kettering Cancer Center, New York
Узраст 1 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07223021

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Тражи се учесникФаза 3
  • Mount Sinai Hospital, New York
  • NYP/Weill Cornell Medical Center, New York
Узраст од 18 до 39 · Оба пола · Ажурирано 3. 11. 2026. · NCT03150693

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Тражи се учесникФаза 1/2
  • Memorial Sloan Kettering Cancer Center ( Site 1010), New York
6 Months – 25 Years · Оба пола · Ажурирано 30. 10. 2026. · NCT06395103

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Тражи се учесникФаза 2
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • Memorial Sloan Kettering Cancer Center, New York
  • NYP/Weill Cornell Medical Center, New York
365 Days · Оба пола · Ажурирано 27. 10. 2026. · NCT06317662

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Тражи се учесникФаза 2
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
  • и још 1
366 Days – 46 Years · Оба пола · Ажурирано 27. 10. 2026. · NCT06124157

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

Тражи се учесникФаза 3
  • David H. Koch Center for Cancer Care, New York
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT07648264

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Тражи се учесникФаза 1/2
  • Research Site, New York
Узраст 12 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT06137118

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Тражи се учесникФаза 2
  • Memorial Sloan Kettering Cancer Center, New York
Узраст од 18 до 54 · Оба пола · Ажурирано 13. 10. 2026. · NCT06918431

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

Тражи се учесникФаза 1
  • Columbia University Irving Medical Center/New York Presbyterian Hospital, New York
Узраст 18 и старији · Оба пола · Ажурирано 8. 9. 2026. · NCT03666000

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Тражи се учесникФаза 3
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • Mount Sinai Hospital, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • и још 2
365 Days – 25 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT03959085

Study of SGR-1505 in Mature B-Cell Neoplasms

Тражи се учесникФаза 1
  • Weill Cornell, New York
Узраст 18 и старији · Оба пола · Ажурирано 13. 2. 2026. · NCT05544019

Studije za Беркитов лимфом u drugim gradovima

Ostale studije u gradu New York City

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.